BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Isoniazid

a tuberculostatic. It remains the treatment of choice for tuberculosis.

299+ PubMed studies analyzed · 13 RCTs · Evidence Score: 46.3

Research Domains

Isoniazid has been studied across 13 research domains including 🫁 Liver & Detox, 🫁 Respiratory, 🔬 Inflammation, 🔬 Oncology, 🫘 Kidney. The primary research focus is 🫁 Liver & Detox with 16% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Isoniazid, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Carbimazole
5 shared targets
Pinacidil
5 shared targets
Iodine
5 shared targets
Methoxsalen
8 shared targets
Propanil
6 shared targets
Prasugrel
5 shared targets
Aztreonam
4 shared targets
Nialamide
6 shared targets
Anastrozole
5 shared targets
idebenone
4 shared targets
Loading evidence profile...

This evidence profile for Isoniazid is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.